Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
From The Norwegian Centre for Movement Disorders (G.A.) and Department of Neurology (G.A.), Stavanger University Hospital, Norway; and the Department of Neuroscience Imaging and Clinical Sciences (L.B.), University G. d'Annunzio of Chieti-Pescara, Italy. algu@sus.no.
Guido
G
Alves
From The Norwegian Centre for Movement Disorders (G.A.) and Department of Neurology (G.A.), Stavanger University Hospital, Norway; and the Department of Neuroscience Imaging and Clinical Sciences (L.B.), University G. d'Annunzio of Chieti-Pescara, Italy.
Laura
L
Bonanni
D006801:Humans; D019636:Neurodegenerative Diseases / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis; D016900:Neurofilament Proteins / Q000134:cerebrospinal fluid*; D020734:Parkinsonian Disorders / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis
D016900:Neurofilament Proteins; C044882:neurofilament protein L